| Polypharmacy and medication-related problems in hemodialysis patients: a call for deprescribing M Alshamrani, A Almalki, M Qureshi, O Yusuf, S Ismail Pharmacy 6 (3), 76, 2018 | 63 | 2018 |
| Practical strategies to manage cancer patients during the COVID-19 pandemic: Saudi Oncology Pharmacy Assembly Experts recommendations M Alshamrani, A AlHarbi, N Alkhudair, F AlNajjar, M Khan, AB Obaid, ... Journal of oncology pharmacy practice 26 (6), 1429-1440, 2020 | 30 | 2020 |
| Experience With Ceftolozane-Tazobactam for the Treatment of Serious Pseudomonas aeruginosa Infections in Saudi Tertiary Care Center M Bosaeed, A Ahmad, A Alali, E Mahmoud, L Alswidan, A Alsaedy, ... Infectious Diseases: Research and Treatment 13, 1178633720905977, 2020 | 21 | 2020 |
| Determinants of employee retention in pharmaceutical companies: Case of Saudi Arabia M Alshamrani, S Alharthi, M Helmi, T Alwadei Journal of Business and Management Studies 5 (2), 08-22, 2023 | 20 | 2023 |
| Prescribing empiric antibiotics for febrile neutropenia: compliance with institutional febrile neutropenia guidelines D Naeem, MA Alshamrani, MA Aseeri, MA Khan Pharmacy 6 (3), 83, 2018 | 20 | 2018 |
| Cancer management in Saudi Arabia: recommendations by the Saudi oncology HeAlth economics ExpeRt GrouP (SHARP) N Alkhudair, M Alshamrani, H Samarkandi, H Almodaheem, ... Saudi Pharmaceutical Journal 29 (2), 115-120, 2021 | 11 | 2021 |
| Emerging role of biosimilars in oncology-hematology in Saudi Arabia: a practical perspective MA Khan, MA Aseeri, MA Alshamrani, AH Alnatsheh, HS Alhamdan Global Journal on Quality and Safety in Healthcare 3 (1), 22-29, 2020 | 10 | 2020 |
| Granulocyte Colony Stimulating Factor (G‐CSF) Induced Splenic Infarction in Breast Cancer Patient Treated with Dose‐Dense Chemotherapy Regimen MA Alshamrani, M Al-Foheidi, AH Abdulrahim Case Reports in Oncological Medicine 2019 (1), 8174986, 2019 | 10 | 2019 |
| Evaluation of handling, storage, and disposal practices of oral anticancer medications among cancer patients and their caregivers at home setting in the Princess Noorah … AA Algethami, MA Alshamrani, AM AlHarbi, AA AlAzmi, MA Khan, ... Journal of Oncology Pharmacy Practice 27 (1), 20-25, 2021 | 6 | 2021 |
| Coping with the residency program during COVID-19: Hematology oncology pharmacy residents’ perspective AA AlAzmi, F AlNajjar, M AlShomrani Journal of Oncology Pharmacy Practice 26 (8), 1942-1946, 2020 | 4 | 2020 |
| Cost-efficiency analysis of conversion to biosimilar filgrastim for supportive cancer care and resultant expanded access analysis to supportive care and early-stage HER2+ … CC Yousef, MA Khan, H Almodaimegh, M Alshamrani, M Al-Foheidi, ... Journal of Medical Economics 26 (1), 394-402, 2023 | 3 | 2023 |
| Comparison of biosimilar filgrastim with innovator fligrastim for peripheral blood stem cells mobilization, collection of CD34+ stem cells, and engraftment in patients … MM Islami, MA Khan, MA Aseeri, MA Alshamrani, A Alnatsheh, ... Annals of Transplantation 28, e938585-1, 2023 | 3 | 2023 |
| Safety and discontinuation rate of immune checkpoint inhibitors used in patients with solid and hematological malignancies. A population based retrospective analysis A Shahbar, M Alshamrani, M Aseeri, T Alfayea, A Alnatsheh Journal of Oncology Pharmacy Practice 28 (4), 771-776, 2022 | 3 | 2022 |
| Effectiveness of a Single 6-mg Fixed Dose of Rasburicase for Prevention or Management of Hyperuricemia Associated with Tumor Lysis Syndrome in Adults with Cancer. MA Khan, MA Alshamrani, MA Aseeri, AS Al Saeed, HS Alhamdan, ... Journal of Hematology Oncology Pharmacy 9 (1), 2019 | 3 | 2019 |
| Pharmacy practitioners’ adherence to safe-handling practices of chemotherapeutic drugs: A cross-sectional study in Saudi Arabia A Ogbaghebriel, M Alshamrani, A Ibrahim, W Al-Masaary, S Hakami, ... Journal of Oncology Pharmacy Practice, 10781552221105584, 2022 | 2 | 2022 |
| The Incidence of Hematological Toxicities in Colorectal Cancer Patients Treated With Fluoropyrimidine-Based Regimens at Princess Noorah Oncology Center M Khan, S Alharbi, S Aljuhani, M Tunkar, A Morya, A Alnatsheh, ... Cureus 15 (8), 2023 | 1 | 2023 |
| Implementing oncology pharmacy boot camp for advanced pharmacy practice experience students at a Regional conference in Saudi Arabia M Alnuhait, A Alharbi, A Alanizi, N Alkhudair, M Alshamrani, E Bajnaid, ... Cureus 15 (2), 2023 | 1 | 2023 |
| Impact of coronavirus of 2019 on the delivery of pharmacy services to patients with cancer: an international survey of oncology pharmacy practitioners G Chazan, J Jupp, T Bauters, N Duncan, KJ Weddle, H Nomura, ... Journal of Oncology Pharmacy Practice 28 (8), 1832-1847, 2022 | 1 | 2022 |
| Opioid-induced respiratory depression and risk factors in a tertiary hospital: A retrospective study NA Almouaalamy, M Alshamrani, WK Alnejadi, ZM Alharbi, FM Aldosari, ... Saudi Pharmaceutical Journal 30 (8), 1095-1100, 2022 | 1 | 2022 |
| Evaluation of tyrosine kinase inhibitor discontinuation initiative in patients with chronic myeloid leukemia at princess noorah oncology center AM Noor, MA Khan, MM Al-Thomali, AH Alnatsheh, AA Absi, FM Hakami, ... Journal of Applied Hematology 13 (3), 126-131, 2022 | 1 | 2022 |
